Olanzapine in PDD

被引：45

作者：

Horrigan, JP

Barnhill, LJ

Courvoisie, HE

机构：

来源：

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 1997年 / 36卷 / 09期

关键词：

D O I：

10.1097/00004583-199709000-00007

中图分类号：

B844 [发展心理学（人类心理学）];

学科分类号：

040202 ;

摘要：

引用

收藏

页码：1166 / 1167

页数：2

相关论文

共 4 条

[1] FIRST CLINICAL-EXPERIENCE WITH OLANZAPINE (LY-170053) - RESULTS OF AN OPEN-LABEL SAFETY AND DOSE-RANGING STUDY IN PATIENTS WITH SCHIZOPHRENIA [J].

BALDWIN, DS ;

MONTGOMERY, SA .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 (04) :239-244

[2] CLINICAL EFFICACY OF SEROTONIN-DOPAMINE ANTAGONISTS RELATIVE TO CLASSIC NEUROLEPTICS [J].

BORISON, RL .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (01) :S24-S29

[3] PHARMACOLOGICAL TREATMENT OF PSYCHIATRIC AND NEURODEVELOPMENTAL DISORDERS IN CHILDREN AND ADOLESCENTS .1. [J].

MCDANIEL, KD .

CLINICAL PEDIATRICS, 1986, 25 (02) :65-71

[4]

RICHARDSON MA, 1991, AM J PSYCHIAT, V148, P1322